Novavax (NVAX) Convertible Debt (2016 - 2025)
Novavax (NVAX) posted Convertible Debt of $244.21 million for Q4 2025, up 43.9% from $169.68 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Convertible Debt (2016 - 2025) Analysis & Trends
Since Q1 2016, Novavax has reported Convertible Debt for 40 quarters.
- Annual Convertible Debt has increased for three consecutive years, though with a five-year compound annual growth rate of -5.4% (FY2020 to FY2025).
- In prior years, Novavax's Convertible Debt was $169.68 million in FY2024 (+1.0%), $168.02 million in FY2023 (+0.9%), $166.47 million in FY2022 (-48.5%) and $323.46 million in FY2021 (+0.4%).
- The Q4 2025 figure stands as the highest quarterly Convertible Debt since Q3 2022.
- On a year-over-year basis, Convertible Debt has increased in each of the last nine quarters, with growth averaging 11.7% over the last eight quarters.
- The strongest year-over-year quarter for Convertible Debt in the past five years was Q3 2025, with growth of 44.1%; the weakest was Q4 2022, with a decline of 48.5%.
- According to Business Quant data, Convertible Debt for the three prior quarters was $243.84 million (Q3 2025), $170.57 million (Q2 2025) and $170.13 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 244.21 Mn |
| Sep 30, 2025 | 243.84 Mn |
| Jun 30, 2025 | 170.57 Mn |
| Mar 31, 2025 | 170.13 Mn |
| Dec 31, 2024 | 169.68 Mn |
| Sep 30, 2024 | 169.27 Mn |
| Jun 30, 2024 | 168.85 Mn |
| Mar 31, 2024 | 168.43 Mn |
| Dec 31, 2023 | 168.02 Mn |
| Sep 30, 2023 | 167.62 Mn |
| Jun 30, 2023 | 167.25 Mn |
| Mar 31, 2023 | 166.86 Mn |
| Dec 31, 2022 | 166.47 Mn |
| Sep 30, 2022 | 324.53 Mn |
| Jun 30, 2022 | 324.17 Mn |
| Mar 31, 2022 | 323.81 Mn |
| Dec 31, 2021 | 323.46 Mn |
| Sep 30, 2021 | 323.10 Mn |
| Jun 30, 2021 | 322.75 Mn |
| Mar 31, 2021 | 322.39 Mn |
API Access
Novavax Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();